Stockscreener 앱 받기
14.71
5.52%
-0.86
시간 외 거래:
14.71
Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스
IDEAYA Biosciences announces board change and new advisory role - Investing.com
Why Ideaya Biosciences Is Down Despite Many Positives (NASDAQ:IDYA) - Seeking Alpha
IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events - BioSpace
IDEAYA Leadership to Showcase Ophthalmology and Oncology Progress at Two Elite Conferences - Stock Titan
Where are the Opportunities in (IDYA) - news.stocktradersdaily.com
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation For Darovasertib Monotherapy In Neoadjuvant Uveal Melanoma - MarketScreener
IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation for Darovasertib Monotherapy in Neoadjuvant Uveal Melanoma - PR Newswire
Indo-Asian News Service - Indo-Asian News Service (IANS)
Ideaya Biosciences stock hits 52-week low at $16.95 By Investing.com - Investing.com South Africa
Ideaya Biosciences stock hits 52-week low at $16.95 - Investing.com
IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GuruFocus
IDEAYA Awards $306K Worth of Stock Options to Strategic New Hire - Stock Titan
IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor - Marketscreener.com
Breakthrough Cancer Treatment: IDEAYA's IDE275 Targets Major Tumor Types with GSK Backing - Stock Titan
(IDYA) Technical Pivots with Risk Controls - Stock Traders Daily
Ideaya Biosciences stock hits 52-week low at $17.28 By Investing.com - Investing.com Australia
Ideaya Biosciences stock hits 52-week low at $17.28 - Investing.com
IDEAYA Biosciences (NASDAQ:IDYA) Shares Gap Up – What’s Next? - Defense World
IDEAYA Announces Further Gilead Sciences Clinical Study Collabor - GuruFocus.com
IDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery Platform - Insider Monkey
Top 10 AI Trending News on Wall Street - Insider Monkey
IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets - BioSpace
IDEAYA Biosciences Partners With ATTMOS To Advance AI/ML-Driven Oncology Drug Discovery - Nasdaq
IDEAYA Biosciences Announces Collaboration with ATTMOS to Accele - GuruFocus.com
Ideaya Biosciences stock hits 52-week low at $19.95 - Investing.com India
Ideaya Biosciences stock hits 52-week low at $19.95 By Investing.com - Investing.com South Africa
IDEAYA Biosciences, ATTMOS Collaborate to Advance Small Molecule Discovery for Undruggable Oncology Targets - Marketscreener.com
IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets – Company AnnouncementFT.com - Financial Times
Rhumbline Advisers Has $2.92 Million Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Rule 5635(c)(4) - Nasdaq
IDEAYA Biosciences Grants Stock Options to 4 New Employees Under Inducement Plan - StockTitan
When the Price of (IDYA) Talks, People Listen - news.stocktradersdaily.com
Fair Value analysis proves accurate as IDEAYA shares drop 41% in 10 months - Investing.com India
IDEAYA Biosciences (NASDAQ:IDYA) Hits New 12-Month LowWhat's Next? - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Issues Quarterly Earnings Results, Misses Expectations By $0.82 EPS - MarketBeat
IDEAYA Biosciences (NASDAQ:IDYA) Sets New 12-Month Low – Here’s Why - Defense World
IDEAYA Biosciences, Inc. SEC 10-K Report - TradingView
Fiera Capital Corp Has $30.44 Million Stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - MarketBeat
IDEAYA Biosciences' SWOT analysis: cancer therapy stock poised for pivotal year - Investing.com
How To Trade (IDYA) - Stock Traders Daily
IDEAYA announces proposed public offering of common stock and pre-funded warrants - MSN
IDEAYA Biosciences (NASDAQ:IDYA) Trading Down 4.8%Time to Sell? - MarketBeat
IDEAYA Biosciences Stock Gains Momentum as Analysts Reaffirm Bullish Outlook - HPBL
IDEAYA Biosciences' (IDYA) "Overweight" Rating Reiterated at Stephens - MarketBeat
Down -8.63% in 4 Weeks, Here's Why You Should You Buy the Dip in IDEAYA Biosciences (IDYA) - MSN
IDEAYA Biosciences (IDYA) Expected to Announce Earnings on Tuesday - MarketBeat
IDEAYA Biosciences Reports 2024 Financials and Business Update - TipRanks
3.01%
자본화:
|
볼륨(24시간):